Multiparametric MR diffusion‐weighted imaging for monitoring the ultra‐early treatment effect of sorafenib in human hepatocellular carcinoma xenografts
Purpose To investigate the value of multiparametric magnetic resonance imaging (MRI)
diffusion‐weighted imaging (DWI) for monitoring the ultra‐early (within 24 hours) treatment …
diffusion‐weighted imaging (DWI) for monitoring the ultra‐early (within 24 hours) treatment …
Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results
C Schraml, NF Schwenzer… - American Journal of …, 2009 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to evaluate signal changes of advanced
hepatocellular carcinoma in diffusion-weighted MRI in the early-response monitoring of oral …
hepatocellular carcinoma in diffusion-weighted MRI in the early-response monitoring of oral …
Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion‐weighted imaging in an …
S Yang, J Lin, F Lu, Z Han, C Fu, P Lv… - Journal of Magnetic …, 2017 - Wiley Online Library
Purpose To investigate the effectiveness of intravoxel incoherent motion (IVIM) in the
assessment of the therapeutic efficacy of sorafenib in an orthotopic hepatocellular …
assessment of the therapeutic efficacy of sorafenib in an orthotopic hepatocellular …
Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging
TY Jeon, CK Kim, JH Kim, GH Im… - The British Journal of …, 2015 - academic.oup.com
Objective: To investigate the feasibility of dynamic contrast-enhanced MRI (DCE-MRI) and
diffusion-weighted MRI (DWI) in monitoring early therapeutic response to sorafenib in renal …
diffusion-weighted MRI (DWI) in monitoring early therapeutic response to sorafenib in renal …
Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of …
NM Muñoz, AA Minhaj, KL Maldonado… - Magnetic Resonance …, 2019 - Elsevier
Objectives To compare the accuracy of contrast-enhanced ultrasound (CEUS) and Dynamic
contrast-enhanced (DCE) magnetic resonance imaging (MRI) for the assessment of …
contrast-enhanced (DCE) magnetic resonance imaging (MRI) for the assessment of …
Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion‐weighted MRI, choline spectroscopy and 18F …
O Karroum, L Mignion, J Kengen… - Contrast media & …, 2013 - Wiley Online Library
The purpose of this study was to determine the value of different imaging modalities, that is,
magnetic resonance imaging/spectroscopy (MRI/MRS) and positron emission tomography …
magnetic resonance imaging/spectroscopy (MRI/MRS) and positron emission tomography …
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and …
BACKGROUND & AIMS: Sorafenib plus metronomic tegafur/uracil therapy can induce tumor
stabilization in advanced hepatocellular carcinoma (HCC) patients. This study evaluated the …
stabilization in advanced hepatocellular carcinoma (HCC) patients. This study evaluated the …
[HTML][HTML] Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
JI Choi, DK Imagawa, P Bhosale… - Clinical and …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinomas are highly vascular tumors, showing progressive
hypervascularity by the process of neoangiogenesis. Tumor angiogenesis is critical for …
hypervascularity by the process of neoangiogenesis. Tumor angiogenesis is critical for …
Perfusion magnetic resonance as a biomarker for sorafenib-treated advanced hepatocellular carcinoma: a pilot study
M Campos, I Candelária, N Papanikolaou… - GE-Portuguese Journal …, 2019 - karger.com
Background: Sorafenib is the currently recommended therapy in patients with advanced
hepatocellular carcinoma (HCC). Among the several biomarkers available for the evaluation …
hepatocellular carcinoma (HCC). Among the several biomarkers available for the evaluation …
[HTML][HTML] Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
Background To investigate the hypothesis that MRI derived diffusion-weighted imaging
(DWI) and perfusion (MRP) parameters are sensitive image biomarkers for monitoring early …
(DWI) and perfusion (MRP) parameters are sensitive image biomarkers for monitoring early …